Cocrystal Pharma shareholders elect directors, ratify auditor, approve 2025 equity plan

Cocrystal Pharma, Inc.

Elected six directors: Kornberg (4,386,691 for), Frost (4,344,444 for), Hassan (4,440,602 for), Japour, Pfenniger, Rubin.
Ratified Weinberg & Company as independent auditor for FY2025 (6,166,964 for, 452,222 against).
Approved 2025 Equity Incentive Plan (3,764,418 for, 714,962 against).
Adjournment proposal moot due to sufficient votes on other proposals.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.